Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor
about
New options in anticoagulation for the prevention of venous thromboembolism and stroke.Application of Molecular Modeling to Development of New Factor Xa InhibitorsAnticoagulant effect and safety assessment of an aqueous extract of Pseudocedrela kotschyi (Schweinf.) harms and Adenia cissampeloides (Planch. Ex Hook.) harmsOptimal release timing of temporary drain clamping after total knee arthroplasty.Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.
P2860
Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@ast
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@en
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@nl
type
label
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@ast
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@en
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@nl
prefLabel
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@ast
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@en
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@nl
P2093
P2860
P3181
P1476
Rivaroxaban (xarelto) for the ...... ral direct factor xa inhibitor
@en
P2093
Anna Nogid
Rahul Bhambri
Younos Abdulsattar
P2860
P304
P3181
P407
P577
2009-05-01T00:00:00Z